Searched for
TRUMP ORDER IMPACT ON GENERIC DRUGS
Why CDSCO and BEE have not kept pace with the industries they overseeCDSCO still faces challenges like chronic understaffing, gaps in technical skills, weak lab infra and fragmented approvals. About a decade ...- Birthright citizenship ruling explained: Supreme Court rejects Donald Trump’s executive order. Will that stop U.S. President from setting criteria for American citizens?Birthright citizenship order, which Donald Trump signed on the first day of his second term, is part of his administration’s broad immigrat...
- Mankind Pharma joins hands with Denovo Sciences for AI-powered drug discoveryMankind Pharma has joined forces with Denovo Sciences to revolutionize drug discovery using artificial intelligence. This strategic partner...
- Indian-American groups, lawmakers welcome US Supreme Court birthright citizenship rulingThe US Supreme Court has upheld birthright citizenship, rejecting President Trump's executive order that sought to deny citizenship to chil...
- Manipur: DGP Mukesh Singh praises Cycle Patrol initiativeManipur DGP Mukesh Singh lauded the Cycle Patrol initiative as a vital tool for beat policing and community engagement, particularly in hil...
- US Supreme Court rejects Donald Trump's bid to restrict birthright citizenshipThe U.S. Supreme Court has delivered a significant blow to President Trump, rejecting his attempt to restrict birthright citizenship for ch...
- 'Cheaper than a gym, but still not selling': Nithin Kamath on why Indians aren't embracing popular weight-loss drugsDespite rising obesity and affordable generic GLP-1 drugs, India lags in adoption. Nithin Kamath highlights patient retention challenges wi...
- US Supreme Court to rule on Trump bid to limit birthright citizenshipThe U.S. Supreme Court is set to decide on President Trump's executive order aiming to restrict birthright citizenship for children of immi...
- Alembic Pharmaceuticals gets USFDA nod for generic acne treatment gelAlembic Pharmaceuticals has secured final USFDA approval for its generic Dapsone gel, a topical treatment for acne vulgaris. This approval,...
- Kiran Mazumdar-Shaw warns against long-term GLP-1 use, urges caution over weight-loss drugs, says 'for those who are not diabetic or clinically obese...'Nithin Kamath questions India's slow adoption of affordable GLP-1 weight-loss drugs, despite rising obesity. He points to challenges like l...
- India’s GLP-1 boom loses steam as price war, weak retention hit generic weight-loss drug salesInitial excitement for India's generic weight-loss drugs is fading. Domestic manufacturers are lowering sales targets due to slower-than-ex...
- Alembic Pharma gets USFDA nod for generic influenza treatment drugAlembic Pharmaceuticals has secured USFDA approval for its generic oseltamivir phosphate oral suspension, a key treatment for influenza. Th...
- Lupin gets USFDA tentative approval for prostate cancer treatment drugIndian pharmaceutical giant Lupin Ltd has secured tentative approval from the US FDA for its generic enzalutamide tablets, a crucial treatm...
- Federal judge halts Trump's election executive order seeking to create a federal voter listUS District Court Judge Indira Talwani, who was nominated by Democratic President Barack Obama, sided with a coalition of nearly two dozen ...
- Trump orders probe because gas prices not falling enoughDonald Trump said on Wednesday he ordered an investigation into major oil companies over high gasoline prices as the US leader faces critic...
- Indian pharma firms gear up to supply key cancer drug to USIndian drugmakers are stepping up to help the US combat a critical shortage of ifosfamide injection, a vital chemotherapy drug. Leading com...
- NITI Aayog proposes pharma chapter for future FTAs, urges India to move up value chainNiti Aayog proposes a blueprint for free trade agreements to boost regulatory predictability in India's pharmaceutical sector. The think ta...
- India's pharma supply chain remains 65 per cent dependent on China for critical inputs: NITI AayogIndia's pharmaceutical sector, despite being the "pharmacy of the world," faces significant reliance on China for raw materials, with nearl...
- Biosimilars and innovation will drive Indian pharma's next growth phase: Vishal ManchandaIndia's pharmaceutical sector is pivoting beyond generics, with companies aggressively pursuing growth in biosimilars, nutraceuticals, and ...
- Alembic Pharma gets tentative nod from USFDA for generic cancer drugAlembic Pharmaceuticals has secured tentative approval from the USFDA for its generic Binimetinib tablets. This marks a significant step fo...
Load More
